Overall survival and cumulative incidence of relapse at 5 years stratified by MRD level immediately before HCT
| Outcome . | ALL . | AML . | ||||
|---|---|---|---|---|---|---|
| MRD− (N = 34) . | MRD+ (N = 30) . | P . | MRD− (N = 33) . | MRD+ (N = 25) . | P . | |
| Survival (95% CI), % | 68.0 (48.2-81.3) | 29.8 (14.0-47.0) | .008 | 67.8 (46.8-82.3) | 46.6 (26.3-64.6) | .05 |
| Relapse (95% CI), % | 6.3 (1.1-17.1) | 27.8 (12.4-46) | .03 | 6.6 (1.1-20.8) | 36.9 (18.3-55.8) | .005 |
| Outcome . | ALL . | AML . | ||||
|---|---|---|---|---|---|---|
| MRD− (N = 34) . | MRD+ (N = 30) . | P . | MRD− (N = 33) . | MRD+ (N = 25) . | P . | |
| Survival (95% CI), % | 68.0 (48.2-81.3) | 29.8 (14.0-47.0) | .008 | 67.8 (46.8-82.3) | 46.6 (26.3-64.6) | .05 |
| Relapse (95% CI), % | 6.3 (1.1-17.1) | 27.8 (12.4-46) | .03 | 6.6 (1.1-20.8) | 36.9 (18.3-55.8) | .005 |